[go: up one dir, main page]

MX2024002190A - Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes. - Google Patents

Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes.

Info

Publication number
MX2024002190A
MX2024002190A MX2024002190A MX2024002190A MX2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A MX 2024002190 A MX2024002190 A MX 2024002190A
Authority
MX
Mexico
Prior art keywords
fucan
transplants
treatment
compositions
conditions related
Prior art date
Application number
MX2024002190A
Other languages
English (en)
Inventor
Christopher Michael Kevin Springate
Ian Millet
Hesong Sun
Original Assignee
Arc Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arc Medical Inc filed Critical Arc Medical Inc
Publication of MX2024002190A publication Critical patent/MX2024002190A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Composiciones y métodos que comprenden fucanos médicamente aceptables adecuados para aplicaciones médicas y quirúrgicas, incluyendo el tratamiento de contracturas capsulares y otras condiciones de reacción ante cuerpos extraños (FBR), y aplicaciones médicas y quirúrgicas relacionadas con trasplantes y operaciones de trasplante, tales como EICH y crecimientos fibrosos alrededor o sobre implantes o trasplantes después de la implantación/trasplante y enfermedades, infecciones y traumatismos relacionados.
MX2024002190A 2021-08-20 2022-08-18 Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes. MX2024002190A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US202263354322P 2022-06-22 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (1)

Publication Number Publication Date
MX2024002190A true MX2024002190A (es) 2024-06-24

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024002190A MX2024002190A (es) 2021-08-20 2022-08-18 Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes.

Country Status (10)

Country Link
US (1) US20240350531A1 (es)
EP (1) EP4387630A4 (es)
JP (1) JP2024532867A (es)
KR (1) KR20240087708A (es)
AU (1) AU2022328865A1 (es)
CA (1) CA3229366A1 (es)
IL (1) IL310940A (es)
MX (1) MX2024002190A (es)
WO (1) WO2023019360A1 (es)
ZA (1) ZA202401941B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757A1 (de) * 2024-02-21 2025-08-21 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
WO2020019079A1 (en) * 2018-07-27 2020-01-30 Arc Medical Devices Inc. Highly purified fucans for the treatment of fibrous adhesions

Also Published As

Publication number Publication date
JP2024532867A (ja) 2024-09-10
KR20240087708A (ko) 2024-06-19
WO2023019360A1 (en) 2023-02-23
AU2022328865A1 (en) 2024-03-14
EP4387630A1 (en) 2024-06-26
US20240350531A1 (en) 2024-10-24
EP4387630A4 (en) 2025-07-30
CA3229366A1 (en) 2023-02-23
ZA202401941B (en) 2025-06-25
IL310940A (en) 2024-04-01

Similar Documents

Publication Publication Date Title
Campoccia et al. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces
Sobczak et al. Hirudotherapy in veterinary medicine
MX2021012558A (es) Metodos innovadores para el tratamiento de las semillas y componentes para mejorar los atributos y el rendimiento de la planta.
CA2656523A1 (en) Flexible bioresorbable hemostatic packing and stent
Hinck et al. Use of vacuum-assisted closure negative pressure wound therapy in combat-related injuries—literature review
Chen et al. Treatment of severe burn with DermACELL®, an acellular dermal matrix
AR084753A1 (es) Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
MX387554B (es) Composiciones microbianas y metodos de uso para favorecer el crecimiento de las plantas y tratar las enfermedades de las plantas.
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
MX2024002190A (es) Composiciones de fucanos y fucanos modificados para el tratamiento de condiciones relacionadas con la contractura capsular y para inhibir crecimientos fibrosos alrededor o en trasplantes.
BRPI0612931B8 (pt) composição para aplicação na pele
MX2022009807A (es) Metodos para tratar y prevenir arritmias por injerto.
Akhtar et al. Inferiorly based thigh flap for reconstruction of defects around the knee joint
WO2019132604A3 (ko) 인간 섬유연골 또는 탄성연골 재생용 조성물
CN103636596A (zh) 一种生物膜保护液及其制备与应用
Pirrelli et al. Aortic graft infections: treatment with arterial allograft
Vallet-Regí et al. New materials and complications of prostheses in humans: situation in Spain
Ramdas et al. Temporary ectopic testicular replantation, refabrication and orthotopic transfer
Al Hussein et al. Minimally invasive surgical protocol for adipose derived stem cells collection and isolation-ovine model
RU2434595C1 (ru) Способ кожной пластики комбинированными кожными аутотрансплантатами при глубоких ожогах кожи
Lander et al. Autologous stromal vascular fraction containing stem cells combined with low intensity shock wave for the treatment of human erectile dysfunction
Harati et al. THE USE OF PRONTOSAN® WOUND GEL X IN PARTIAL AND FULL THICKNESS BURNS REQUIRING SPLIT THICKNESS SKIN GRAFTS-AN INTERIM ANALYSIS (174)
Wong et al. Total ear replantation using the distal radial artery perforator
Jablecki et al. Unilateral arm transplant 28 years after amputation: fourteen-month result